drugset / Trial / NCT00913796
Metabolic Acidosis in Renal Transplant Patients
Phase 2
Completed
30 enrolled
University of Zurich
Swiss Federal Institute of Technology · collabUniversity of Texas Southwestern Medical Center · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Acidosis (accumulation of acid in the body) may be an underrecognized problem in patients after renal transplantation. It may have consequences on physical performance due to negative effects on bone and muscle metabolism. Therefore, the purpose of this study is 1. to determine the status of physical capacity and bone structure in renal transplant patients with metabolic acidosis 2. to study the effect of substituting base equivalents (citrate) on acid/base status of renal transplant patients with acidosis 3. to compare the status of physical capacity and bone structure in renal transplant patients with metabolic acidosis before and after substitution with citrate
Timeline
- Start
- 2007-12
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | POTASSIUM CITRATE ANHYDROUS | Small molecule | 2.41 g | — |
| Comparator | Potassium Chloride | Small molecule | 370 mg | — |